ADMA BiologicsADMA

ADMA Biologics

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and othersat risk for certain infectious diseases.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Mr. Adam S. Grossman

$3B

Market Cap • 12/07/2024

2004

(há 20 anos)
Fundação

2013

(11 years ago)
IPO

NASDAQ

Listagem
Flag of US

Ramsey

Sede • New Jersey

617

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

ADMASó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

7%

1 dia

09/07/2024

12%

1 semana

05/07/2024

19%

1 mês

12/06/2024

268%

1 ano

12/07/2023

214%

5 anos

12/07/2019

10 anos

Histórico